Literature DB >> 26271451

Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study.

N W Andersson1, L N Gustafsson1, N Okkels1, F Taha2, S W Cole3, P Munk-Jørgensen1, R D Goodwin2.   

Abstract

BACKGROUND: Autoimmune diseases are associated with substantial morbidity and mortality, yet the etiology remains unclear. Depression has been implicated as a risk factor for various immune-related disorders but little is known about the risk of autoimmune disease. This study examined the association between depression and the risk of autoimmune disease, and investigated the temporal and dose-response nature of these relationships.
METHOD: A prospective population-based study including approximately 1.1 million people was conducted using linked Danish registries. Depression and autoimmune diseases were diagnosed by physicians and documented in medical records. In total, 145 217 individuals with depression were identified between 1995 and 2012. Survival analyses were used to estimate the relative risk of autoimmune disease among those with, compared to without, depression. Analyses were adjusted for gender, age, and co-morbid mental disorders.
RESULTS: Depression was associated with a significantly increased risk of autoimmune disease [incidence rate ratio (IRR) 1.25, 95% CI 1.19-1.31], compared to those without a history of depression. Results suggest a general increased risk of autoimmune diseases following the onset of depression during first year (IRR 1.29, 95% CI 1.05-1.58), which remained elevated for the ensuing 11 years and beyond (IRR 1.53, 95% CI 1.34-1.76). Findings did not support a dose-response relationship.
CONCLUSIONS: Depression appears to be associated with an increased risk of a range of autoimmune diseases. Depression may play a role in the etiology of certain autoimmune conditions. If replicated, findings could highlight additional clinical implications in the treatment and management of depression. Future studies are needed to investigate the possible social, genetic, and neurobiological underpinnings of these relationships.

Entities:  

Keywords:  Autoimmune disease; depression; epidemiology; humans; longitudinal studies; prospective studies

Mesh:

Year:  2015        PMID: 26271451     DOI: 10.1017/S0033291715001488

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  25 in total

Review 1.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 2.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

3.  Depressive symptoms are associated with salivary shedding of Epstein-Barr virus in female adolescents: The role of sex differences.

Authors:  Jodi L Ford; Raymond P Stowe
Journal:  Psychoneuroendocrinology       Date:  2017-09-07       Impact factor: 4.905

Review 4.  Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells.

Authors:  Eléonore Beurel; Eva M Medina-Rodriguez; Richard S Jope
Journal:  Pharmacol Rev       Date:  2022-04       Impact factor: 25.468

5.  Causal association of juvenile idiopathic arthritis-associated uveitis with depression and anxiety: a bidirectional Mendelian randomization study.

Authors:  Jun Zhang; Shuqiong Hu; Xiang Luo; Changwei Huang; Qingfeng Cao
Journal:  Int Ophthalmol       Date:  2022-08-10       Impact factor: 2.029

6.  Association of Depression With Risk of Incident Systemic Lupus Erythematosus in Women Assessed Across 2 Decades.

Authors:  Andrea L Roberts; Laura D Kubzansky; Susan Malspeis; Candace H Feldman; Karen H Costenbader
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

7.  The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder.

Authors:  Alix Arnaud; Ellison Suthoff; Rita M Tavares; Xuan Zhang; Aditi J Ravindranath
Journal:  Pharmacoeconomics       Date:  2021-04-28       Impact factor: 4.981

8.  Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance.

Authors:  Jerry Guintivano; Karolina A Aberg; Shaunna L Clark; David R Rubinow; Patrick F Sullivan; Samantha Meltzer-Brody; Edwin J C G van den Oord
Journal:  Mol Psychiatry       Date:  2022-04-01       Impact factor: 13.437

9.  Impact of treatment delays on vitiligo during the COVID-19 pandemic: A retrospective study.

Authors:  Xinya Xu; Chengfeng Zhang; Min Jiang; Leihong Flora Xiang
Journal:  Dermatol Ther       Date:  2021-06-16       Impact factor: 3.858

10.  Distinct non-inflammatory signature of microglia in post-mortem brain tissue of patients with major depressive disorder.

Authors:  Gijsje J L J Snijders; Marjolein A M Sneeboer; Alba Fernández-Andreu; Evan Udine; Marco P Boks; Paul R Ormel; Amber Berdenis van Berlekom; Hans C van Mierlo; Chotima Bӧttcher; Josef Priller; Towfique Raj; Elly M Hol; René S Kahn; Lot D de Witte
Journal:  Mol Psychiatry       Date:  2020-10-07       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.